Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 21 hours agoSince then, the stock has trended lower. The vaccine is based on protein technology,...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 21 hours agoHowever, he adds that we still don’t have great treatments for COVID, with Paxlovid being the only ...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 7 hours agoThe double-blinded, randomised trial will compare CVXGA's efficacy, safety, and immunogenicity...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 7 days agoThe Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
Good Morning America via Yahoo News· 4 days agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN.com· 4 days agoCalling the outcome of the late-stage trial “breakthrough results,” Moderna’s Chief Medical Affairs...
US government to fund up to $500 mln for studies on oral, nasal COVID vaccines
Reuters· 19 hours agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced...
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 4 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance via AOL· 3 days agoModerna (MRNA) is on its way to getting a third mRNA-based vaccine approved by the FDA if the...